Biomarkers of Therapeutic Response in Melanoma Research Program

Program Overview

These programs are focused on transitioning established basic science into clinical applications. Specifically, our studies are investigating the potential for use of kinetic changes in plasma circulating tumor DNA and peripheral mononuclear cell phenotypes as diagnostic biomarkers for use in prognostication of therapeutic response and early detection of drug resistance. 

Details about our Program